Binnopharm Group brands are winners of the Russian Pharma Awards® 2023

Binnopharm Group brands became winners in several categories of the annual Russian Pharma Awards®

The antispasmodic Neobutin® is the leader in the nomination «Physicians' Choice in Functional Gastrointestinal Disorders», Kagocel® also took the first place in the nomination «Antiviral drug No. 1 with the possibility of delayed start of treatment». Ciprolet® became the second «Broad-spectrum antibiotic from the group of fluoroquinolones», and the non-steroidal anti-inflammatory drug Naisulid® took the third place in the nomination «Selective COX-2 inhibitor for pain syndrome».

Anton Fedosyuk, Marketing Director of Binnopharm Group: «We are grateful for the high evaluation of our brands by specialists. This is direct evidence that the drugs produced by Binnopharm Group are necessary for the market and patients. Also, these awards confirm the professionalism and efficient work of the Binnopharm Group team».

The 12th Russian Pharma Awards® ceremony took place on November 30, 2023. More than 20 nominations and more than 70 nominated drugs were presented at the ceremony. More than 430,000 practicing physicians were invited to vote.

Russian Pharma Awards® is the annual award in the field of pharmacy and medicine. It is the only award in Russia where the winners are determined solely on the basis of the experience and expertise of practicing specialists. Winning the award means recognition in the industry by the most demanding audience — doctors.